MyFinsight
Home
Blog
About
Contact
Download
Download image
Effect of exchange rate
changes on cash
$45K
Net change in cash,
cash equivalents,...
-$87,405K
Canceled cashflow
$45K
Impairment of
indefinite-lived intangible and...
$56,700K
Stockbased compensation
expense
$10,521K
Loss on change in fair
value of cvr liability
$4,354K
Depreciation and
amortization
$2,959K
Loss on impairment of
investment
$2,000K
Accounts payable
$1,066K
Noncash lease expense
$778K
Proceeds from exercise of
stock options
$323K
Net cash used in
operating activities
-$73,941K
Net cash (used in)
provided by financing...
-$8,055K
Net cash used in
investing activities
-$5,454K
Canceled cashflow
$78,378K
Canceled cashflow
$323K
Other (income)
expense, net
$13,103K
Total revenues
$2,797K
Net loss
-$130,302K
Distribution of contingent
value rights
$7,754K
Equity offering costs
$624K
Purchases of property and
equipment
$5,454K
Canceled cashflow
$15,900K
(benefit) provision for
deferred taxes
-$9,193K
Prepaid expenses and
other assets
$5,298K
Gain on change in fair
value of warrant...
-$3,695K
Accrued expenses and
other liabilities
-$3,588K
Accounts receivable
$243K
Impairment of
indefinite-lived intangible and...
$56,700K
General and
administrative
$31,468K
Research and
development-Descartes08For MG
$22,893K
Research and
development-Research And Development...
$16,826K
Research and
development-Research And Development...
$7,748K
Research and
development-Early Stage Programs
$5,795K
Research and
development-Research And Development...
$4,772K
Back
Back
Cash Flow
source: myfinsight.com
Cartesian Therapeutics, Inc. (RNAC)
Cartesian Therapeutics, Inc. (RNAC)